Clinical Trial Update: Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating a hemoglobin-based oxygen carrier used during elective percutaneous coronary rev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Occlusion
• Coronary Syndrome

Drugs mentioned

• Hemopure (HBOC-201)

Snippet

Sponsor: Biopure Corporation | Conditions: Coronary Occlusion, Acute Coronary Syndrome | Phase 2 | Status: COMPLETED